MasTec (MTZ) – Investment Analysts’ Weekly Ratings Changes
by Kim Johansen · The Markets DailySeveral brokerages have updated their recommendations and price targets on shares of MasTec (NYSE: MTZ) in the last few weeks:
- 10/12/2026 – MasTec had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $348.00 price target on the stock.
- 10/8/2026 – MasTec had its price target lowered by Stifel Nicolaus from $376.00 to $305.00. They now have a “buy” rating on the stock.
- 10/7/2026 – MasTec was given a new $352.00 price target by Mizuho.
- 10/5/2026 – MasTec had its price target lowered by TD Cowen from $420.00 to $320.00. They now have a “buy” rating on the stock.
- 10/5/2026 – MasTec had its price target lowered by Truist Financial Corporation from $428.00 to $380.00. They now have a “buy” rating on the stock.
- 9/28/2026 – MasTec had its price target lowered by Piper Sandler from $321.00 to $313.00. They now have a “neutral” rating on the stock.
- 9/8/2026 – MasTec is now covered by Piper Sandler. They set an “overweight” rating and a $321.00 price target on the stock.
- 9/8/2026 – MasTec was upgraded by Piper Sandler to “strong-buy”.
- 8/26/2026 – MasTec was downgraded by Zacks Research from “strong-buy” to “hold”.
- 8/17/2026 – MasTec was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
MasTec, Inc is an infrastructure construction and engineering company that provides installation, maintenance and upgrade services for communications, energy and utility networks. Its communications work includes wireless and wireline infrastructure, fiber-optic networks, broadband systems and related engineering and construction services.
The company also supports the development and maintenance of energy infrastructure. Its activities include construction services for renewable energy projects, power transmission and distribution systems, natural gas and oil pipelines, and other industrial infrastructure.
Featured Stories
- Five stocks we like better than MasTec
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit